TABLE 2.

Relationship between clinical features and YTHDF2 expression in LIHC patients (logistic regression).

Clinical characteristics	TCGA-LIHC			ICGC-LIRI-JP
	Total (N)	OR (95%CI)	p-value	Total (N)	OR (95%CI)	p-value
Age (continuous)	370	0.99 (0.98–1.01)	0.23	232	0.99 (0.97–1.02)	0.68
Gender (female vs. male)	371	0.88 (0.57–1.36)	0.56	231	2.38 (1.31–4.43)	0.01
Grade (poor vs. well)	365	1.66 (1.09–2.57)	0.03	NA
T classification (T3-T4 vs. T1)	274	2.51 (1.51–4.22)	0.01	NA
M classification (M1 vs. M0)	270	0.33 (0.02–2.60)	0.34	NA
Stage (II vs. I)	257	2.16 (1.28–3.67)	0.00	142	1 (0.47–2.14)	1
Stage (III–IV vs. I)	261	2.56 (1.52–4.35)	0.00	126	1.26 (0.86–1.88)	0.24
Stage (IV vs. I)	NA			55	1.50 (1.03–2.27)	0.04
Stage (III + IV vs. I + II)	261	1.26 (0.86–1.88)	0.24	232	1.67 (0.98–2.85)	0.06

OR, Odds ratio; CI, confidence interval. Bold values indicate p < 0.05. p < 0.05 was considered statistically significant.